GSK484 |
Mixed-mode inhibitor of PADI4
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PADI4 |
|
Mixed-mode inhibitor
Up to 10 uM
Selectivity
In Vitro Selectivity Assessment
Potency: Ki, Kii - PADI1: Ki = 108 uM, Kii = 470 uM, PADI2 Ki = 107 uM, Kii = 1350 uM, PADI3 Ki = 2090 uM, Kii = 1230 uM, PADI4 Ki = 6.8 uM, Kii = 65 uM
Selectivity Assessment Description:
Negligible activity in a panel of 50 protein kinases Negligible activity against COX2, MAOB, PDE4 ...
Potency Cellular
In Vitro
PADI4
Mode of Action: Mixed-mode inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1038/nchembio.1735
Negative Control Compounds
GSK106
Chemical Information
| Molecular Formula | C27H31N5O3 |
| SMILEs | COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12 |
| InChI | InChI=1S/C27H31N5O3/c1-30-25-20(11-18(13-24(25)35-2)27(34)31-10-9-23(33)19(28)15-31)29-26(30)22-12-17-5-3-4-6-21(17)32(22)14-16-7-8-16/h3-6,11-13,16,19,23,33H,7-10,14-15,28H2,1-2H3/t19-,23+/m0/s1 |
| Molecular weight | 473.24 Da |
| AlogP | 3.147700000000002 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 66 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.